We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Latest News
Mike Story Joins Scientific Advisory Board of Protein Discovery
News

Mike Story Joins Scientific Advisory Board of Protein Discovery

Mike Story joins a distinguished roster of fellow scientists and inventors on Protein Discovery's scientific advisory board.
Metabolon Closes $8 Million Series B Funding Round
News

Metabolon Closes $8 Million Series B Funding Round

These funds will allow Metabolon to make substantial progress toward its commercialization goals.
Lawrence J. Murphy Appointed to Third Wave Board of Directors
News

Lawrence J. Murphy Appointed to Third Wave Board of Directors

Mr. Murphy, 63, brings to Third Wave’s board 30 years of business experience.
Key Heart and Alzheimer's Disease Protein Imaged in Native State
News

Key Heart and Alzheimer's Disease Protein Imaged in Native State

The work focuses on apoE4, one of three specific forms of apolipoprotein E, commonly known as apoE.
Identifying Tumour Gene Signatures with TaqMan®
News

Identifying Tumour Gene Signatures with TaqMan®

Applied Biosystems technology has been used to investigate gene expression patterns in cancer.
Fluidigm Announces Former Intel Executive as new CFO
News

Fluidigm Announces Former Intel Executive as new CFO

Richard DeLateur has been appointed as Chief Financial Officer.
De Novo Announces Drug Discovery Collaboration with Genzyme
News

De Novo Announces Drug Discovery Collaboration with Genzyme

De Novo will apply its molecular structure generating technology to focus on a disease target of interest to Genzyme.
Clinical Data Announces Collaborative Research Agreement with UPCI
News

Clinical Data Announces Collaborative Research Agreement with UPCI

Clinical Data will apply metabolomics analysis to serum samples from a population of patients diagnosed with lung cancer.
Caprion Announces Biomarker Discovery Collaboration with ICOS
News

Caprion Announces Biomarker Discovery Collaboration with ICOS

The agreement in biomarker discovery will use Caprion's CellCarta® proteomics discovery platform.
Alnylam Announces Allowance of U.S. Patent Covering RNAi Therapeutics
News

Alnylam Announces Allowance of U.S. Patent Covering RNAi Therapeutics

Patent rights for Tuschl II are held exclusively by Alnylam for development and commercialization of RNAi therapeutics.
Advertisement